160 related articles for article (PubMed ID: 12283954)
1. [Application of anti-progesterone agents for contraception].
Taketani Y; Mizuno M
Rinsho Fujinka Sanka; 1988; 42(11):997-1000. PubMed ID: 12283954
[TBL] [Abstract][Full Text] [Related]
2. RU 486: an overview of mifepristone and its potential applications.
Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
[TBL] [Abstract][Full Text] [Related]
3. Contraception by the progesterone antagonist RU 486: a novel approach to human fertility control.
Baulieu EE
Res Reprod; 1987 Jan; 19(1):3-4. PubMed ID: 12314576
[TBL] [Abstract][Full Text] [Related]
4. Antiprogestogens: from abortion to contraception.
Prog Hum Reprod Res; 1992; (22):6-7. PubMed ID: 12286013
[TBL] [Abstract][Full Text] [Related]
5. [A new antiprogestational compound, mifepristone (RU-486)].
Parisi C; Steffe M
Patol Clin Ostet Ginecol; 1988; 16(4):291-4. PubMed ID: 12345008
[TBL] [Abstract][Full Text] [Related]
6. The clinical use of RU 486 (Mefipristone).
Herrmann W
Res Reprod; 1989 Oct; 21(4):3. PubMed ID: 12282921
[TBL] [Abstract][Full Text] [Related]
7. [Clinical application of an antiprogesterone preparation, RU 486].
Taketani Y; Ishihara T; Go M; Mizuno M
Rinsho Fujinka Sanka; 1988; 42(3):229-33. PubMed ID: 12286721
[TBL] [Abstract][Full Text] [Related]
8. Abortion. Is RU 486/PG in its current form likely to be appropriate for women in Bangladesh?
Kabir S; Germain A
Newsl Womens Glob Netw Reprod Rights; 1992; (38):39-45. PubMed ID: 12285435
[TBL] [Abstract][Full Text] [Related]
9. Life after Roe v. Wade.
Bauerlein M
Utne Read; 1992; ():17-20. PubMed ID: 12343822
[TBL] [Abstract][Full Text] [Related]
10. Progesterone antagonists on the horizon.
Spitz IM; Bardin CW
Clin Obstet Gynecol; 1989 Jun; 32(2):403-13. PubMed ID: 2663280
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive technologies: how much choice do we really have?
Fishel J
ZPG Report; 1997; 29(2):4-6. PubMed ID: 12293118
[TBL] [Abstract][Full Text] [Related]
12. RU 486 licensed in Sweden.
IPPF Med Bull; 1992 Dec; 26(6):6. PubMed ID: 12346922
[TBL] [Abstract][Full Text] [Related]
13. Antiprogesterones.
Norman J
Br J Hosp Med; 1991 Jun; 45(6):372-5. PubMed ID: 2070168
[TBL] [Abstract][Full Text] [Related]
14. Fertility regulation technology: status and prospects.
Segal SJ; Nordberg OS
Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
[TBL] [Abstract][Full Text] [Related]
15. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
Rozenbaum H
Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
[TBL] [Abstract][Full Text] [Related]
16. RU-486: learning more about the French abortion drug.
Smith L
Sun; 1994 May; ():1D, 5D. PubMed ID: 12346325
[TBL] [Abstract][Full Text] [Related]
17. The pregnancy protecting effect of progesterone against human chorionic gonadotrophin challenge in mares.
Allen WE
Ir Vet J; 1976 Feb; 30(2):23-7. PubMed ID: 12277645
[TBL] [Abstract][Full Text] [Related]
18. [Hormone profile in plasma and amniotic fluid during mid-trimester abortion induced by tricosanthin and by Rivanol].
Wang YF; Liu JX; Jin YC; Peng XY
Shengzhi Yu Biyun; 1982 Sep; 2(3):15-8. PubMed ID: 12312670
[TBL] [Abstract][Full Text] [Related]
19. RU-486: the experience of users.
Girault-laurence J
Plan Parent Eur; 1991 Sep; 20(2):21. PubMed ID: 12284549
[TBL] [Abstract][Full Text] [Related]
20. News in contraception.
Contracept Rep; 1994 Jul; 5(3):14. PubMed ID: 12287814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
